The Aortic Stenosis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the aortic stenosis has expanded quickly in the past few years. It is set to increase from $7.88 billion in 2024 to $8.93 billion in 2025, with the Compound Annual Growth Rate (CAGR) being 13.3%.
The Aortic Stenosis Global Market is projected to reach a market size of $14.54 billion in 2029, growing at a compound annual growth rate (CAGR) of 12.9%.
Download Your Free Sample of the 2025 Aortic Stenosis Market Report and Uncover Key Trends Now!The key drivers in the aortic stenosis market are:
• Rising adoption of minimally invasive procedures
• Expanding geriatric population
• Increasing healthcare expenditure
• Advancements in aortic valve replacement technologies
The aortic stenosis market covered in this report is segmented –
1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis
2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty
3) By Administration: Oral, Parenteral, Implants
4) By Distribution Channel: Offline, Online
5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy
Subsegments:
1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis
2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis
The key trends in the aortic stenosis market are:
• A trend towards the increased use of minimally invasive procedures is emerging.
• Advancements in aortic valve replacement technologies are shaping the market’s future.
• Innovations in Transcatheter Aortic Valve Replacement (TAVR) are a significant trend.
• The use of artificial intelligence in diagnostics is a growing trend.
Major players in the aortic stenosis market are:
• AstraZeneca plc
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Terumo Corporation
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• LivaNova PLC
• Meril Life Sciences Pvt Ltd.
• Shockwave Medical Inc.
• Venus Medtech
• Egnite Inc.
• JenaValve Technology Inc
• Peijia Medical
• Micro Interventional Devices Inc
• CryoLife Inc.
• Coroneo Meril Life Sciences Pvt Ltd
• Thubrikar Aortic Valve Inc.
• Anteris Technologies Ltd.
• Cardiawave
North America was the largest region in the aortic stenosis market in 2024